Search: onr:"swepub:oai:lup.lub.lu.se:eafb86a6-8810-4b93-8882-732363b8ff58" >
TGFβ attenuates tum...
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
-
- Mariathasan, Sanjeev (author)
- Genentech, Inc
-
- Turley, Shannon J. (author)
- Genentech, Inc
-
- Nickles, Dorothee (author)
- Genentech, Inc
-
show more...
-
- Castiglioni, Alessandra (author)
- Genentech, Inc
-
- Yuen, Kobe (author)
- Genentech, Inc
-
- Wang, Yulei (author)
- Genentech, Inc
-
- Kadel, Edward E. (author)
- Genentech, Inc
-
- Koeppen, Hartmut (author)
- Genentech, Inc
-
- Astarita, Jillian L. (author)
- Genentech, Inc
-
- Cubas, Rafael (author)
- Genentech, Inc
-
- Jhunjhunwala, Suchit (author)
- Genentech, Inc
-
- Banchereau, Romain (author)
- Genentech, Inc
-
- Yang, Yagai (author)
- Genentech, Inc
-
- Guan, Yinghui (author)
- Genentech, Inc
-
- Chalouni, Cecile (author)
- Genentech, Inc
-
- Ziai, James (author)
- Genentech, Inc
-
- Şenbabaoǧlu, Yasin (author)
- Genentech, Inc
-
- Santoro, Stephen (author)
- Genentech, Inc
-
- Sheinson, Daniel (author)
- Genentech, Inc
-
- Hung, Jeffrey (author)
- Genentech, Inc
-
- Giltnane, Jennifer M. (author)
- Genentech, Inc
-
- Pierce, Andrew A. (author)
- Genentech, Inc
-
- Mesh, Kathryn (author)
- Genentech, Inc
-
- Lianoglou, Steve (author)
- Genentech, Inc
-
- Riegler, Johannes (author)
- Genentech, Inc
-
- Carano, Richard A.D. (author)
- Genentech, Inc
-
- Eriksson, Pontus (author)
- Lund University,Lunds universitet,Genomiska analyser av urinblåscancer,Forskargrupper vid Lunds universitet,Urothelial Cancer Genomics,Lund University Research Groups
-
- Höglund, Mattias (author)
- Lund University,Lunds universitet,Genomiska analyser av urinblåscancer,Forskargrupper vid Lunds universitet,Urothelial Cancer Genomics,Lund University Research Groups
-
- Somarriba, Loan (author)
- Fios Genomics
-
- Halligan, Daniel L. (author)
- Fios Genomics
-
- Van Der Heijden, Michiel S. (author)
- Netherlands Cancer Institute
-
- Loriot, Yohann (author)
- University of Paris-Saclay
-
- Rosenberg, Jonathan E. (author)
- Memorial Sloan-Kettering Cancer Center
-
- Fong, Lawrence (author)
- UCSF Helen Diller Family Comprehensive Cancer Center
-
- Mellman, Ira (author)
- Genentech, Inc
-
- Chen, Daniel S. (author)
- Genentech, Inc
-
- Green, Marjorie (author)
- Genentech, Inc
-
- Derleth, Christina (author)
- Genentech, Inc
-
- Fine, Gregg D. (author)
- Genentech, Inc
-
- Hegde, Priti S. (author)
- Genentech, Inc
-
- Bourgon, Richard (author)
- Genentech, Inc
-
- Powles, Thomas (author)
- Queen Mary University
-
show less...
-
(creator_code:org_t)
- 2018-02-14
- 2018
- English 5 s.
-
In: Nature. - : Springer Science and Business Media LLC. - 0028-0836 .- 1476-4687. ; 554:7693, s. 544-548
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://europepmc.or...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients with various cancers, including metastatic urothelial cancer. However, these responses only occur in a subset of patients. Elucidating the determinants of response and resistance is key to improving outcomes and developing new treatment strategies. Here we examined tumours from a large cohort of patients with metastatic urothelial cancer who were treated with an anti-PD-L1 agent (atezolizumab) and identified major determinants of clinical outcome. Response to treatment was associated with CD8 + T-effector cell phenotype and, to an even greater extent, high neoantigen or tumour mutation burden. Lack of response was associated with a signature of transforming growth factor β (TGFβ) signalling in fibroblasts. This occurred particularly in patients with tumours, which showed exclusion of CD8 + T cells from the tumour parenchyma that were instead found in the fibroblast-and collagen-rich peritumoural stroma; a common phenotype among patients with metastatic urothelial cancer. Using a mouse model that recapitulates this immune-excluded phenotype, we found that therapeutic co-Administration of TGFβ-blocking and anti-PD-L1 antibodies reduced TGFβ signalling in stromal cells, facilitated T-cell penetration into the centre of tumours, and provoked vigorous anti-Tumour immunity and tumour regression. Integration of these three independent biological features provides the best basis for understanding patient outcome in this setting and suggests that TGFβ shapes the tumour microenvironment to restrain anti-Tumour immunity by restricting T-cell infiltration.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
-
Nature
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Mariathasan, San ...
-
Turley, Shannon ...
-
Nickles, Dorothe ...
-
Castiglioni, Ale ...
-
Yuen, Kobe
-
Wang, Yulei
-
show more...
-
Kadel, Edward E.
-
Koeppen, Hartmut
-
Astarita, Jillia ...
-
Cubas, Rafael
-
Jhunjhunwala, Su ...
-
Banchereau, Roma ...
-
Yang, Yagai
-
Guan, Yinghui
-
Chalouni, Cecile
-
Ziai, James
-
Şenbabaoǧlu, Yas ...
-
Santoro, Stephen
-
Sheinson, Daniel
-
Hung, Jeffrey
-
Giltnane, Jennif ...
-
Pierce, Andrew A ...
-
Mesh, Kathryn
-
Lianoglou, Steve
-
Riegler, Johanne ...
-
Carano, Richard ...
-
Eriksson, Pontus
-
Höglund, Mattias
-
Somarriba, Loan
-
Halligan, Daniel ...
-
Van Der Heijden, ...
-
Loriot, Yohann
-
Rosenberg, Jonat ...
-
Fong, Lawrence
-
Mellman, Ira
-
Chen, Daniel S.
-
Green, Marjorie
-
Derleth, Christi ...
-
Fine, Gregg D.
-
Hegde, Priti S.
-
Bourgon, Richard
-
Powles, Thomas
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Nature
- By the university
-
Lund University